Huckman, Robert S., Gary P. Pisano, and Mark Rennella. "Wyeth Pharmaceuticals: Spurring Scientific Creativity with Metrics." Harvard Business School Case 607-008, February 2007. (Revised April 2010.) ...

In 2014, Wyeth received a favorable court ruling that rejected claims that the company made a "reverse payment" to Teva to delay the launch of Effexor XR generic.However, an appeals court in ...

Prior to teaching, Karen worked for Wyeth Pharmaceuticals as a protein chemist in product development. Her research focused on purification of novel proteins as potential drug therapeutics. She ...

14 days Prescribing information Etanercept powder Enbrel (Immunex Corporation [Amgen and Wyeth Pharmaceuticals]) 7 days Manufacturer Etanercept prefilled syringe Enbrel (Immunex Corporation [Amgen ...

The Pfizer-Wyeth merger has some worried that a wave of consolidation may occur among large pharmaceutical firms, leaving cash-strapped biotech companies with fewer potential partners or buyers.

The money was left over from SAC's $602 million settlement in March 2013 with the U.S. Securities and Exchange Commission over trades in drugmakers Wyeth and Elan by Mathew Martoma, who worked at ...

Appointment Deepens Financial and Operational Expertise of Boardas Company Approaches Potential Commercialization SOUTH SAN ...